RA Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,000,000
| Closed | -$84.6M | – | 88 |
|
|
2024
Q4 | $84.6M | Hold |
1,000,000
| – | – | 1.13% | 22 |
|
|
2024
Q3 | $89.9M | Hold |
1,000,000
| – | – | 1.04% | 28 |
|
|
2024
Q2 | $80.5M | Hold |
1,000,000
| – | – | 1.06% | 26 |
|
|
2024
Q1 | $79.8M | Hold |
1,000,000
| – | – | 1.02% | 28 |
|
|
2023
Q4 | $79.6M | Hold |
1,000,000
| – | – | 1.24% | 24 |
|
|
2023
Q3 | $69.9M | Hold |
1,000,000
| – | – | 1.38% | 22 |
|
|
2023
Q2 | $71.9M | Buy |
+1,000,000
| New | +$71.9M | 1.36% | 21 |
|
|
2021
Q3 | – | Sell |
-1,655,447
| Closed | -$112M | – | 97 |
|
|
2021
Q2 | $112M | Hold |
1,655,447
| – | – | 1.79% | 15 |
|
|
2021
Q1 | $93.7M | Hold |
1,655,447
| – | – | 1.41% | 19 |
|
|
2020
Q4 | $135M | Sell |
1,655,447
-379,685
| -19% | -$30.9M | 1.89% | 11 |
|
|
2020
Q3 | $145M | Hold |
2,035,132
| – | – | 2.65% | 7 |
|
|
2020
Q2 | $167M | Buy |
2,035,132
+131,038
| +7% | +$10.8M | 3.26% | 7 |
|
|
2020
Q1 | $112M | Buy |
1,904,094
+1,536,278
| +418% | +$90.4M | 3.54% | 6 |
|
|
2019
Q4 | $38M | Sell |
367,816
-296,569
| -45% | -$30.7M | 1.15% | 21 |
|
|
2019
Q3 | $13.4M | Sell |
664,385
-676,443
| -50% | -$13.7M | 0.8% | 24 |
|
|
2019
Q2 | $34.5M | Sell |
1,340,828
-1,952,961
| -59% | -$50.3M | 1.85% | 15 |
|
|
2019
Q1 | $46.9M | Buy |
+3,293,789
| New | +$46.9M | 2.02% | 14 |
|